Health :: Drugs & Medications

Could legalizing all drugs solve America’s opioid epidemic?

bostonherald.com

Could legalizing all drugs solve America’s opioid epidemic?


Read More ...

Baltimore Health Department seeks to double buprenorphine treatment

baltimoresun.com

Baltimore Health Department seeks to double buprenorphine treatment


Read More ...

City asks judge to let case against OxyContin maker proceed

ktvn.com

City asks judge to let case against OxyContin maker proceed


Read More ...

Bernie’s Medicare for All Act of 2017 Would Even Cover Complementary And Integrative Medicine

inquisitr.com

Bernie’s Medicare for All Act of 2017 Would Even Cover Complementary And Integrative Medicine


Read More ...

Feds bust Houston, international scammers who sold fake flea medicine for pets

chron.com

Feds bust Houston, international scammers who sold fake flea medicine for pets


Read More ...

Jefferson Hospital Sued Over Stolen Pain Medication

cnn.com

Jefferson Hospital Sued Over Stolen Pain Medication


Read More ...

Firefighter charged with possessing illegal firearm, drugs

wcvb.com

Firefighter charged with possessing illegal firearm, drugs


Read More ...

Popular Stories

Home / United States / Health / Drugs & Medications
Buy Pfizer because of its blockbuster breast cancer drug: Morgan Stanley
Pfizer shares have been lagging the market this year. But the stock's fortunes will improve, according to one big Wall Street firm. Morgan Stanley raised its rating for Pfizer shares to overweight from equal-weight Wednesday, predicting strong performance from one of the company's cancer drugs. "We believe investors underappreciate the global prospects for Pfizer's #1 growth driver Ibrance (breast cancer)," analyst David Risinger wrote in a note to clients   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
New Delaware law will expand cancer treatment options
NEWARK, Del. (AP) — Cancer patients in Delaware will soon have more treatment options. A bill signed Wednesday by Gov. John Carney requires health insurers to cover any medically appropriate drug that has been approved by the Food and Drug Administration for the treatment of stage 4 metastatic cancer and other cancers, without requiring proof that the patient failed to respond to a different drug or drugs   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States |  Delaware | 
First Prescription App for Substance Abuse Approved by FDA
Drug and alcohol users will soon be able to get prescriptions for a mobile app that could help them stay clean. Developed by Pear Therapeutics in Boston and San Francisco, the app helps people recovering from addiction stay on track while participating in outpatient treatment. The U.S. Food and Drug Administration (FDA) last week approved the prescription-only software for the American market   Read More ...
Categories: Technology |  Health | 
Places: North America |  United States | 
FDA warns on mixing opioid addiction treatments, other meds
By LINDA A. JOHNSON AP Medical Writer TRENTON, N.J. (AP) - The Food and Drug Administration has issued new warnings about the dangers of combining medication for opioid addiction with antidepressants and other drugs that also slow breathing and brain activity. The FDA warns that mixing such drugs can cause difficulty breathing, coma or death and should be done with caution   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States | 
Drugs reported stolen from Franciscan Health Lafayette East pharmacy
  Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States |  Midwest |  East |  Indiana | 
FDA warns on mixing opioid addiction treatments, other meds
TRENTON, N.J. (AP) — The Food and Drug Administration has issued new warnings about the dangers of combining medication for opioid addiction with antidepressants and other drugs that also slow breathing and brain activity. The FDA warns that mixing such drugs can cause difficulty breathing, coma or death and should be done with caution. Many patients fighting opioid addiction by taking methadone or buprenorphine (byoo-preh-NOR'-feen) also take other prescription drugs that slow action of the central nervous system   Read More ...
Categories: Health | 
Tags: Drugs & Medications |  Patients |  Treatment | 
Places: Americas |  North America |  United States | 
Alnylam's RNAi drug succeeds in key study, shares soar
(Reuters) - Alnylam Pharmaceuticals Inc’s RNAi-based drug that targets a rare genetic disease met the main goal of a key study, in a breakthrough for the new class of medicines that works by blocking disease-causing proteins. The company’s shares soared as much as 55.8 percent to a more than two-year high of $116.93 in afternoon trading on Wednesday. Alnylam’s patisiran belongs to a class of drugs that uses the Nobel-prize winning RNA interference (RNAi) mechanism to manipulate ribonucleic acid, which interferes with or “silences” targeted genes, and stops the formation of proteins that can cause diseases   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
FDA warns on mixing opioid addiction treatments, other meds
TRENTON, N.J. (AP) — The Food and Drug Administration has issued new warnings about the dangers of combining medication for opioid addiction with antidepressants and other drugs that also slow breathing and brain activity. The FDA warns that mixing such drugs can cause difficulty breathing, coma or death and should be done with caution. Many patients fighting opioid addiction by taking methadone or buprenorphine (byoo-preh-NOR'-feen) also take other prescription drugs that slow action of the central nervous system   Read More ...
Categories: Health | 
Tags: Drugs & Medications |  Patients |  Treatment | 
Places: Americas |  North America |  United States | 
Alnylam's RNAi drug clears key study, shares soar
(Reuters) - Alnylam Pharmaceuticals Inc’s RNAi-based drug that targets a rare genetic disease cleared a key study, in a breakthrough for the new class of medicines that works by blocking disease-causing proteins. The company’s shares soared as much as 55.8 percent to hit a more than two-year high at $116.93 in afternoon trading on Wednesday. Alnylam’s patisiran belongs to a class of drugs that uses the Nobel-prize winning RNA interference (RNAi) mechanism to manipulate ribonucleic acid, which interferes with or “silences” targeted genes, and stops the formation of proteins that can cause diseases   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Could legalizing all drugs solve America’s opioid epidemic?
Drug policy in the U.S. is at a crossroads. On one hand, at least 22 states have decriminalized recreational marijuana, eight of which have gone a step further by legalizing it altogether. At least 29 states permit medical marijuana for qualifying patients. Several additional states look poised to consider legalization, decriminalization, or medicalization in 2018. At the federal level, Sen. Cory Booker (D-NJ) has introduced a bill to end the national prohibition of marijuana   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: North America |  United States | 
Alnylam's genetic disease drug succeeds key study, shares soar
(Reuters) - Alnylam Pharmaceuticals Inc’s drug to treat a rare genetic disease cleared a key study, moving the company closer to filing a marketing application for the drug, which is part of a new class of medicines that block disease-causing proteins. The company’s shares soared as much as 38.4 percent to hit a 21-month high in morning trading on Wednesday. Alnylam’s drug, patisiran, belongs to a class of drugs that use RNA interference (RNAi) technology based on manipulating ribonucleic acid to interfere with or “silence” targeted genes in order to prevent the formation of proteins that can cause diseases   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
UPDATE 2-Alnylam's genetic disease drug succeeds key study, shares soar
  Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
The world is running out of antibiotics, WHO says
By Susan Scutti CNN (CNN) -- Too few new antibiotics are under development to combat the threat of multidrug-resistant infections, according to a new World Health Organization report published Tuesday. Adding to the concern: It is likely that the speed of increasing resistance will outpace the slow drug development process. As of May, a total of 51 antibiotics and 11 biologicals -- medical products often made from natural sources -- are being developed, the new report said   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
BRIEF-Jaguar Health says FDA indicates co's Canalevia drug qualifies as “minor use” for exercise-induced diarrhea in dogs
Sept 20 (Reuters) - Jaguar Health Inc: * FDA indicates that jaguar’s Canalevia drug product candidate qualifies as “minor use” for Exercise-Induced Diarrhea (EID) in dogs, rendering Canalevia eligible for conditional approval for this indication * Jaguar Health Inc - expects to conduct commercial launch of Canalevia in first half of 2018 for EID and CID in dogs Source text   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Alnylam's genetic disease drug clears key study, shares soar
(Reuters) - Alnylam Pharmaceuticals Inc said its drug to treat patients suffering from a rare genetic disease met the main goal in a late-stage study, moving the company closer to filing a marketing application for the drug in late 2017. The company’s shares soared 22.2 percent to $91.70 in premarket trading on Wednesday. The drug, patisiran, was being evaluated for the treatment of hereditary ATTR (hATTR) amyloidosis patients with polyneuropathy, which affects about 50,000 people worldwide, Alnylam said   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Alnylam's genetic disease drug meets main goal in key study
Sept 20 (Reuters) - Alnylam Pharmaceuticals Inc said on Wednesday its drug met the main goal in a late-stage study in patients suffering from a life-threatening genetic disease. The drug, patisiran, was being evaluated for the treatment of hereditary ATTR (hATTR) amyloidosis patients with polyneuropathy, which affects the peripheral nerves. The company said it intends to file a marketing application for the drug in late 2017   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Shire, Shionogi's ADHD drug for adults clears late-stage trial in Japan
TOKYO (Reuters) - Shire Plc and Shionogi & Co Ltd said a drug to treat ADHD in adults had met its main goal in a late-stage trial in Japan, bringing it one step closer to approval in the world’s third-biggest market for ADHD treatments. It is the first clinical trial evaluating the drug, Intuniv, in patients aged 18 and over, the drugmakers said, adding that it is already approved in Japan for treatment in younger patients   Read More ...
Categories: Health | 
Places: United States |  Asia |  N.E. Asia |  Japan | 
BRIEF-Kiadis Pharma receives FDA regenerative medicine advanced therapy (RMAT) designation for ATIR101
Sept 20 (Reuters) - KIADIS PHARMA NV: * KIADIS PHARMA RECEIVES FDA REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION FOR ATIR101™ * IN EUROPE ATIR101 WAS FILED FOR REGISTRATION IN APRIL 2017 AND WE CONTINUE TO PREPARE COMPANY FOR POTENTIAL EUROPEAN LAUNCH IN 2019 - CEO Source text for Eikon: Further company coverage: (Gdynia Newsroom) Our Standards:   Read More ...
Categories: Health | 
Places: United States | 
UK backs Opdivo for lung cancer after Bristol-Myers cuts price
LONDON (Reuters) - Bristol-Myers Squibb’s immunotherapy drug Opdivo has been recommended for some patients with lung cancer by Britain’s healthcare cost watchdog NICE after the drugmaker agreed a discounted price. The National Institute for Health and Care Excellence (NICE) said on Wednesday that about 1,300 patients with lung cancer were expected to receive the drug through the Cancer Drugs Fund as a result of the deal   Read More ...
Categories: Health | 
Places: United States | 
WHO warns the world is running out of antibiotics
Concern about growing global antibiotic resistance has come to a head: The World Health Organization is now warning that the world is running out of antibiotics. There aren’t enough truly new antibiotics being developed, especially for the most concerning antibiotic-resistant infections, according to a WHO report released Tuesday. The United Nations health agency has aired its concerns about antibiotic resistance, which makes it more difficult to treat infections, for some time   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
The world is running out of antibiotics, WHO says
Not enough drugs target the 12 "priority pathogens," which are increasingly resistant to existing antibiotics Most drugs in the pipeline will be only short-term solutions (CNN)Too few new antibiotics are under development to combat the threat of multidrug-resistant infections, according to a new World Health Organization report published Tuesday. Adding to the concern: It is likely that the speed of increasing resistance will outpace the slow drug development process   Read More ...
Categories: Health | 
Places: United States | 
Myrtle Beach dental assistant charged with obtaining prescription drugs illegally while on the job
MYRTLE BEACH, SC (WMBF) – A dental assistant was arrested Monday for allegedly obtaining prescription sedatives unlawfully while on the job. According to online records from the J. Reuben Long Detention Center, Kathleen Capra, 48, was charged with theft of controlled substances. She was released Monday evening on a $1,000 bond. An arrest warrant from the South Carolina Department of Health and Environmental Control states the suspect unlawfully obtained a quantity of alprazolam, or Xanax, and took it while performing her duties as a dental assistant at a Myrtle Beach area dentist’s office located on Cipriana Drive   Read More ...
Categories: Health |  Law & Crime | 
Places: Americas |  North America |  United States |  South |  Atlantic |  South Carolina |  Myrtle Beach |  Beach | 
Baltimore Health Department seeks to double buprenorphine treatment
The Baltimore Health Department wants to offer the heroin addiction treatment drug buprenorphine at its HIV clinics as part of a plan to double within a year the number of patients in the city who can get the medicine. Using the city clinics to distribute buprenorphine could make it available to more patients at a time when overdose deaths are cutting a swath through the city and officials say more treatment is desperately needed   Read More ...
Categories: Health | 
Tags: Drugs & Medications |  Patients |  Treatment | 
Places: Americas |  North America |  United States |  South |  Atlantic |  Maryland |  Baltimore | 
The Latest: Lawyer: Pharmacist didn't contaminate the drugs
BOSTON (AP) — The Latest on the trial of a Massachusetts pharmacist charged in a deadly nationwide meningitis outbreak caused by contaminated steroids (all times local): The attorney for a pharmacist charged in a deadly meningitis outbreak traced to tainted steroids says there is no evidence the man caused the drugs to become contaminated. Stephen Weymouth told jurors during his opening statement Tuesday that prosecutors overreached by charging Glenn Chin with second-degree murder under federal racketeering law   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Pharmacist put speed over safety before outbreak
BOSTON (AP) — A pharmacist accused of making the drugs that caused a deadly nationwide meningitis outbreak showed a "shocking disregard" for human life by failing to ensure the medicines were safe, a prosecutor told jurors as his trial opened Tuesday. Glenn Chin, the supervisory pharmacist at the now-closed New England Compounding Center, ran the clean rooms where the drugs were made   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
FDA OKs Glaxo's inhaler, first one to combine 3 medicines
By LINDA A. JOHNSON AP Medical Writer TRENTON, N.J. (AP) - The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis. The FDA late Monday approved sales of Trelegy Ellipta, developed jointly by GlaxoSmithKline PLC and Innoviva Inc. It contains three widely used types of medicine to prevent - rather than treat -flare-ups of the life-threatening breathing disorders   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States | 
Opioids shorten US life expectancy by 2.5 months
(CNN)Opioid drugs -- including both legally prescribed painkillers such as oxycodone and hydrocodone, as well as illegal drugs such as heroin or illicit fentanyl -- are not only killing Americans, they are shortening their overall life spans. Opioids take about 2½ months off our lives, according to a new analysis published in the medical journal JAMA. In 2015, American life expectancy dropped for the first time since 1993   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: United States | 
Pharmacy school cancels classes on growing medical marijuana
BALTIMORE (AP) — A university's pharmacy school has cancelled classes on growing medical marijuana. The Baltimore Sun reported Monday that the University of Maryland appears to be concerned about how the Trump Administration will enforce federal marijuana laws. Medical marijuana has been legalized in nearly 30 states, including Maryland. And Maryland state law requires workers who are employed by growers, processors, dispensaries and laboratories to have training in their areas   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States |  Baltimore | 
BRIEF-Aerie Pharmaceuticals names Tori Arens VP of drug product manufacturing
Sept 19 (Reuters) - Aerie Pharmaceuticals Inc * Aerie Pharmaceuticals announces appointment of Tori Arens as vice president of drug product manufacturing and Eric Carlson, Ph.D. as vice president of research and development Source text for Eikon: Further company coverage: Our Standards:   Read More ...
Categories: Business |  Health | 
Places: Americas |  North America |  United States | 
GlaxoSmithKline breathes easier as U.S. approves triple lung drug
LONDON (Reuters) - U.S. regulators have approved GlaxoSmithKline’s three-in-one inhaler for chronic lung disease, a key new product for the group as it strives to keep its lead in respiratory medicine despite falling sales of the older drug Advair. Trelegy Ellipta is the first once-daily triple medicine for chronic obstructive pulmonary disease (COPD), putting Britain’s biggest drugmaker ahead of rivals such as AstraZeneca and Novartis   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
GlaxoSmithKline breathes easier as US approves triple lung drug
LONDON: U.S. regulators have approved GlaxoSmithKline's three-in-one inhaler for chronic lung disease, a key new product for the group as it strives to keep its lead in respiratory medicine despite falling sales of the older drug Advair. Trelegy Ellipta is the first once-daily triple medicine for chronic obstructive pulmonary disease (COPD), putting Britain's biggest drugmaker ahead of rivals such as AstraZeneca and Novartis   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States |  Singapore | 
Smiths Medical confirms drug pump vulnerable to cyberhacking
Smiths Medical, the Plymouth-based maker of hospital infusion pumps, confirmed earlier this month cybersecurity vulnerabilities in its Medfusion 4000 drug pumps, which are used in pediatric cases worldwide. The company said Monday that it has received no reports of computer hackers exploiting the vulnerabilities. The U.S. Homeland Security Department published an advisory Sept. 7 revealing that three versions of Smiths Medical's Medfusion 4000 drug infusion pump contain vulnerabilities that would allow a skilled computer hacker to remotely take control of the device and alter how it dispenses drugs   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States | 
City asks judge to let case against OxyContin maker proceed
By PHUONG LE Associated Press SEATTLE (AP) - A Washington city that says the pain medication OxyContin has devastated the community asked a federal judge Monday to let it move forward with its lawsuit seeking to hold the pill's manufacturer accountable for damages. Everett, a working-class city of about 108,000 north of Seattle, sued Connecticut-based Purdue Pharma in January, alleging the company knowingly allowed pills to be funneled into the black market and into the city and did nothing to stop it   Read More ...
Categories: Health |  Law & Crime | 
Places: Americas |  North America |  United States |  Seattle | 
UC Irvine aims to transform public health with record-breaking $200-million donation
Susan Samueli caught a cold while visiting France more than three decades ago. Instead of the usual medicines, a friend suggested aconite, a homeopathic remedy derived from a plant in the buttercup family. She was cured — and became a lifelong advocate of homeopathy and other alternative healing methods to complement conventional medicine. Her husband, Henry — the billionaire co-founder of Broadcom, the Irvine semiconductor maker — says he was initially skeptical but found the integrative health approach helped him easily shake off colds and flus and kept their children healthy without antibiotics   Read More ...
Categories: Health | 
Places: Americas |  North America |  United States | 
Christie: Drugmakers to work on nonaddictive pain medication
New Jersey Gov. Chris Christie says pharmaceutical companies have agreed to work on nonaddictive pain medications and additional treatments to deal with opioid addiction.   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States | 
Drugmakers to work on nonaddictive pain medication
TRENTON, N.J. (AP) — New Jersey Gov. Chris Christie said Monday that pharmaceutical companies agreed to work on nonaddictive pain medications and additional treatments to deal with opioid addiction. The Republican governor made the announcement in Trenton, shortly after he convened a meeting of the White House opioid commission that he chairs. That roundtable discussion was closed to the press. He also held a news conference on the topic alongside White House counselor Kellyanne Conway, as well as National Institutes of Health Director Dr   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States | 
Family says Weber County showed ‘deliberate indifference’ when inmate going through withdrawals from drugs died of dehydration
The husband of a Utah woman who died of dehydration at the Weber County jail is now suing the county over her death. Marion Dena Herrera, 40, died two days after she was booked into the jail on suspicion of forgery and theft on May 18, 2016. A day after her arrest, Herrera was moved to the medical unit for a “heroin detox treatment,” according to the lawsuit filed Friday in federal court   Read More ...
Categories: Health |  Society & Culture |  Law & Crime | 
Tags: Drugs & Medications |  Death & Dying |  Prisons |  Prisoners |  Obituary |  Died | 
Places: Americas |  North America |  United States |  West |  Mountain |  Utah | 
Drugmakers to work on nonaddictive pain medication
TRENTON, N.J. (AP) — New Jersey Gov. Chris Christie says pharmaceutical companies have agreed to work on nonaddictive pain medications and additional treatments to deal with opioid addiction. The Republican governor made the announcement in Trenton on Monday, shortly after he convened a meeting of the White House opioid commission that he chairs. He also held a news conference on the topic alongside White House counselor Kellyanne Conway   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States | 
Drugmakers to work on nonaddictive pain medication
TRENTON, N.J. (AP) - New Jersey Gov. Chris Christie says pharmaceutical companies have agreed to work on nonaddictive pain medications and additional treatments to deal with opioid addiction. The Republican governor made the announcement in Trenton on Monday, shortly after he convened a meeting of the White House opioid commission that he chairs. He also held a news conference on the topic alongside White House counselor Kellyanne Conway   Read More ...
Categories: Health | 
Tags: Drugs & Medications | 
Places: Americas |  North America |  United States | 
University of Maryland pharmacy school cancels plans to train medical marijuana workers
The University of Maryland’s School of Pharmacy canceled plans to offer training for those who work in the medical marijuana industry amid legal concerns. After consulting with the Maryland attorney general’s office, the university asked pharmacy school officials to cancel the classes, a university spokesman said. While marijuana has been legalized for medical purposes in Maryland, 28 other states and the District of Columbia, the administration of President Donald Trump has not indicated how it will handle enforcement of the federal marijuana law, which still classifies the drug alongside heroin and LSD   Read More ...
Categories: Health |  Education | 
Places: Americas |  North America |  United States |  South |  Atlantic |  Maryland |